Inbrain Neuroelectronics
Developing high density and high resolution graphene intelligent Brain Computer Interface (BCI) Therapeutics for central and peripheral modulation.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor investor investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
* | €4.0m | Grant | |
| Total Funding | 000k | ||
| EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 79 % | 234 % | 60 % | 8 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | (32 %) | (195 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (74 %) | (222 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates, Company filings or news article
Related Content
Operator of a medical device company pionnering real time precision therapeutics. The company uses graphene to develop BCI-Tx technology that can read and modulate the brain at micrometric neuron-size resolution restoring function real time and helping patients to obtain optimal results in personalized neurological therapies.
Keywords: Pharmaceuticals and Biotechnology, Artificial Intelligence Technology, Bioelectronics Devices, Brain Computer Interface, Neural System, Neuro Sciences, Neuroelectronic Cell, Neurological Therapeutics, Neurological Therapy, Neurological Therapy Provider, Neurotechnology, Peripheral Nerve Modulation.